With diabetes seeing an uptick and India being the Diabetes Capital of...
A major trend in 2025 was the rise of anti-obesity drugs. Mounjaro, in...
Changing Trade Landscape Signals a New Chapter in India–U.S. Pha...
To appreciate the Indian companies and individuals for their commendab...
The 2024 New Drugs & Clinical Trials (Amendment) Rules have receiv...
You have had an inspiring professional journey with deep contributions...
India stands as the fourth-largest medical devices market in A...
Earlier this year, Immuneel Therapeutics achieved a significant milest...
The patent war can become uglier at times and the pharma industry is n...
India is emerging as a key player in global immunotherapy, backed by s...
The landmark Structural Heart Innovation event, held at Meril Academy,...
The current state of obesity in India is alarming. As was evident from...
AI is rapidly transforming healthcare, particularly in diagnostics and...
From telemedicine to AI-driven diagnostics, India is leveraging digita...
Meril Life Sciences announced one-year results...
The grand ceremony featured a ribbon-cutting by K.V.G.K. Raju, an este...
The first 'similar biologic' was approved and marketed in India for a ...
Print is Still King: Why BioSpectrum India's Print Edition Deserves a ...
